With over 17 years of marketing experience in the Bio/Pharma & CDMO industry, Kim Yang, Managing Director at Iridium Strategy Solutions, LLC (ISS), has proven to deliver the highest level of results and products to her clients. Previously as the Global Marketing Director of AGC Biologics, Kim had spearheaded all the marketing activities involved to launch the rebrand of AGC and successfully marketed the company’s capabilities as a leading CDMO via traditional as well as non-traditional marketing tools and platforms. Among her many other responsibilities, she also has experience with the development and management of content for Corporate Communications, to include internal communication plans, press releases, and public relations activities. Before AGC, she has had other marketing & communications roles and responsibilities from Lonza, BioReliance, Becton Dickinson, and Genzyme Corporation that has critically enriched Kim’s service portfolio and has enable her to successfully develop, plan and execute for her clients.
With Kim Yang’s experience in the CDMO industry, Iridium Strategy Solutions, LLC. will deliver above and beyond for all your marketing needs.